Merck wins U.S. ZETIA® (ezetimibe) / VYTORIN® (ezetimibe/simvastatin) patent infringement lawsuit
27 April 2012 | By Merck
"The court appropriately ruled that the patent for ZETIA and VYTORIN in the U.S. is valid..."
List view / Grid view
News
Novo Nordisk A/S expects to elect new chairman in 2013
27 April 2012 | By Novo Nordisk
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation...
GlaxoSmithKline receives European authorisation for Nimenrix™
27 April 2012 | By GlaxoSmithKline
The European Commission has granted marketing authorisation for Nimenrix...
Novartis drug Afinitor® approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
26 April 2012 | By Novartis
The FDA has approved Afinitor® tablets...
FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma
26 April 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved Votrient® (pazopanib)...
Phenomenex creates centralized interactive resource for Kinetex core-shell HPLC/UHPLC column users
26 April 2012 | By Phenomenex Inc
Phenomenex Inc., introduces the “Kinetex Experience”...
More than 25,000 Novartis associates worldwide to volunteer for local causes in Community Partnership Day
26 April 2012 | By Novartis
Novartis associates to dedicate 200,000 work hours to supporting the local community...
GSK and University of Nottingham collaborate to create Centre of Excellence for sustainable chemistry
26 April 2012 | By GlaxoSmithKline
Innovative carbon neutral laboratory to be established on University Campus...
5th Tecan Symposium to visit Boston in the fall
26 April 2012 | By Tecan
The annual Tecan Symposium will be held in the US for the first time this year...
David Brennan to retire as AstraZeneca’s Chief Executive Officer
26 April 2012 | By AstraZeneca
AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire...
Amgen receives Complete Response Letter from FDA for XGEVA® sBLA for prevention of bone metastases
26 April 2012 | By Amgen
The FDA cannot approve the application in its present form...
DiversityInc names Lilly a top company for diversity
25 April 2012 | By Eli Lilly and Company
Eli Lilly and Company has been named to the 2012 DiversityInc Top 50 Companies for Diversity list...
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
25 April 2012 | By AstraZeneca
AstraZeneca and The Medicines Company announced a global collaboration...
Novartis drug Signifor® approved in the EU as the first medication to treat patients with Cushing’s disease
25 April 2012 | By Novartis
Novartis announced that the European Commission has approved Signifor®...
Amgen to acquire Mustafa Nevzat
25 April 2012 | By Amgen
Amgen and Mustafa Nevzat Pharmaceuticals have announced an agreement under which Amgen will acquire 95.6 percent of shares in MN...
